Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

Christina Aquilante

Concepts (357)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacogenetics
30
2025
179
6.420
 Why?
Pharmacogenomic Testing
15
2025
65
4.450
 Why?
Thiazolidinediones
8
2016
137
2.700
 Why?
Aryl Hydrocarbon Hydroxylases
10
2014
48
2.360
 Why?
Heart Transplantation
9
2024
749
2.240
 Why?
Polymorphism, Genetic
17
2019
658
2.120
 Why?
Organ Transplantation
3
2024
248
1.750
 Why?
Cytochrome P-450 CYP3A
8
2024
88
1.650
 Why?
Precision Medicine
11
2025
426
1.590
 Why?
Genotype
20
2025
1920
1.510
 Why?
Tacrolimus
3
2024
199
1.460
 Why?
Polymorphism, Single Nucleotide
11
2024
2193
1.450
 Why?
Cytochrome P-450 CYP2C19
6
2024
24
1.380
 Why?
Health Personnel
4
2021
699
1.310
 Why?
Hypoglycemic Agents
11
2020
1285
1.270
 Why?
Transplant Recipients
6
2024
180
1.250
 Why?
Decision Support Systems, Clinical
2
2024
219
1.220
 Why?
Graft Rejection
3
2024
623
1.100
 Why?
Blood Pressure
8
2020
1776
1.090
 Why?
Metabolic Syndrome
4
2016
354
1.050
 Why?
Cytochrome P-450 CYP2D6
4
2022
30
1.020
 Why?
Pharmacists
3
2022
260
0.920
 Why?
Immunosuppressive Agents
6
2024
891
0.910
 Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
4
2024
442
0.790
 Why?
Cost-Benefit Analysis
3
2024
593
0.780
 Why?
Gemfibrozil
2
2013
11
0.760
 Why?
Hepatocyte Nuclear Factor 1-alpha
1
2021
17
0.730
 Why?
Sulfonylurea Compounds
3
2018
48
0.730
 Why?
Leukopenia
1
2021
31
0.730
 Why?
Adiponectin
2
2016
241
0.720
 Why?
Hypolipidemic Agents
2
2013
92
0.720
 Why?
Warfarin
4
2024
149
0.710
 Why?
Mycophenolic Acid
1
2021
117
0.680
 Why?
Organic Anion Transporters
2
2011
16
0.680
 Why?
Desogestrel
5
2021
46
0.680
 Why?
Biological Specimen Banks
2
2024
102
0.670
 Why?
Platelet Aggregation Inhibitors
1
2024
460
0.670
 Why?
Humans
82
2025
137514
0.630
 Why?
Hypertension
3
2020
1293
0.630
 Why?
Prescription Drugs
2
2020
110
0.620
 Why?
Cytochrome P-450 CYP2C8
7
2014
15
0.600
 Why?
Cardiologists
1
2018
46
0.600
 Why?
Adult
43
2024
37821
0.600
 Why?
Middle Aged
41
2024
33355
0.590
 Why?
Dipeptidyl-Peptidase IV Inhibitors
2
2021
46
0.570
 Why?
HIV Protease Inhibitors
4
2016
69
0.550
 Why?
Physicians
3
2021
904
0.550
 Why?
Ritonavir
4
2012
73
0.540
 Why?
Academic Medical Centers
1
2020
498
0.530
 Why?
Male
48
2024
67718
0.520
 Why?
Female
52
2024
73162
0.520
 Why?
Polypharmacy
1
2017
85
0.500
 Why?
Heart Failure
4
2017
2222
0.500
 Why?
Lectins
1
2016
49
0.490
 Why?
Nonprescription Drugs
1
2016
66
0.490
 Why?
Antiviral Agents
1
2021
740
0.470
 Why?
Attitude of Health Personnel
2
2020
1169
0.470
 Why?
Dihydrouracil Dehydrogenase (NADP)
2
2025
2
0.460
 Why?
Dihydropyrimidine Dehydrogenase Deficiency
2
2025
2
0.460
 Why?
Medicare
1
2020
747
0.450
 Why?
Cytochrome P-450 Enzyme System
2
2006
158
0.450
 Why?
Death, Sudden, Cardiac
3
2021
184
0.440
 Why?
Contraceptive Agents, Female
3
2020
80
0.440
 Why?
Pediatrics
2
2021
1123
0.420
 Why?
Chemokine CXCL5
3
2012
11
0.410
 Why?
Blood Pressure Determination
1
2014
156
0.410
 Why?
Arrhythmias, Cardiac
3
2021
331
0.400
 Why?
Heptanoic Acids
1
2013
66
0.400
 Why?
Anticoagulants
3
2024
665
0.380
 Why?
Pyrazines
1
2013
92
0.380
 Why?
Resistin
2
2010
11
0.380
 Why?
Pharmaceutical Preparations
3
2009
179
0.370
 Why?
Pravastatin
1
2011
41
0.370
 Why?
Pyrroles
1
2013
211
0.370
 Why?
Triazoles
1
2013
151
0.370
 Why?
Retrospective Studies
15
2024
15628
0.360
 Why?
Diabetes Mellitus, Type 2
5
2020
2521
0.360
 Why?
Dobutamine
3
2008
39
0.360
 Why?
Health Knowledge, Attitudes, Practice
4
2021
1332
0.360
 Why?
Cross-Sectional Studies
8
2020
5427
0.350
 Why?
Managed Care Programs
2
2022
129
0.340
 Why?
Aged
19
2024
23798
0.330
 Why?
Antidepressive Agents
2
2022
239
0.320
 Why?
Mixed Function Oxygenases
2
2008
44
0.320
 Why?
DNA
1
2016
1460
0.310
 Why?
Drug Interactions
5
2017
409
0.310
 Why?
Chromatography, Liquid
1
2010
433
0.300
 Why?
Polymerase Chain Reaction
3
2006
1061
0.300
 Why?
Drug Prescriptions
4
2021
251
0.290
 Why?
Health
1
2008
84
0.290
 Why?
International Normalized Ratio
2
2024
47
0.290
 Why?
Sulfonamides
1
2011
513
0.280
 Why?
Chemokine CCL2
1
2008
117
0.280
 Why?
Cytokines
1
2016
2095
0.280
 Why?
Antimetabolites, Antineoplastic
2
2025
94
0.280
 Why?
Time Factors
8
2020
6817
0.280
 Why?
Young Adult
13
2021
13243
0.280
 Why?
Drug Implants
4
2021
82
0.270
 Why?
Receptors, Adrenergic, beta
1
2008
127
0.270
 Why?
Mass Spectrometry
1
2010
741
0.270
 Why?
Fluorouracil
2
2025
213
0.270
 Why?
Matrix Metalloproteinase 8
1
2006
8
0.270
 Why?
Haplotypes
5
2013
491
0.270
 Why?
Heart Rate
3
2008
831
0.260
 Why?
Blood Glucose
3
2016
2183
0.260
 Why?
United States
12
2025
14696
0.260
 Why?
Sequence Analysis, DNA
4
2012
812
0.260
 Why?
Vitamin K Epoxide Reductases
3
2020
12
0.250
 Why?
Metoprolol
1
2006
40
0.250
 Why?
Blood Coagulation Factors
1
2006
54
0.250
 Why?
Electronic Health Records
3
2024
1040
0.250
 Why?
Clinical Laboratory Techniques
1
2006
97
0.250
 Why?
Prospective Studies
7
2024
7598
0.250
 Why?
Autonomic Nervous System
1
2006
80
0.240
 Why?
Models, Biological
1
2013
1775
0.240
 Why?
Clinical Protocols
2
2017
268
0.240
 Why?
Administration, Oral
4
2016
814
0.240
 Why?
Capecitabine
1
2025
46
0.230
 Why?
Genetic Variation
3
2019
986
0.230
 Why?
Echocardiography
1
2008
659
0.230
 Why?
Echocardiography, Stress
1
2004
25
0.230
 Why?
Polymorphism, Restriction Fragment Length
1
2004
68
0.220
 Why?
Cross-Over Studies
3
2013
561
0.220
 Why?
Adverse Drug Reaction Reporting Systems
1
2024
78
0.220
 Why?
Adrenergic beta-Antagonists
1
2006
324
0.210
 Why?
Follow-Up Studies
5
2024
5139
0.210
 Why?
Carrier Proteins
1
2008
770
0.210
 Why?
United States Food and Drug Administration
1
2024
208
0.210
 Why?
Biotransformation
2
2013
68
0.210
 Why?
Cytochrome P-450 CYP2C9
4
2019
20
0.210
 Why?
Cohort Studies
7
2021
5730
0.210
 Why?
Metformin
1
2007
328
0.200
 Why?
Alleles
6
2012
891
0.200
 Why?
Waist Circumference
2
2016
143
0.200
 Why?
Gene Frequency
4
2013
521
0.200
 Why?
Antimalarials
2
2013
32
0.190
 Why?
Dose-Response Relationship, Drug
4
2024
2066
0.180
 Why?
Clinical Trials as Topic
1
2006
1047
0.180
 Why?
Aged, 80 and over
5
2024
7593
0.180
 Why?
Drug Dosage Calculations
1
2020
23
0.180
 Why?
Calcineurin Inhibitors
1
2021
72
0.170
 Why?
Pharmacogenomic Variants
2
2021
35
0.170
 Why?
Egypt
1
2020
11
0.170
 Why?
Antibiotics, Antineoplastic
1
2021
130
0.170
 Why?
Atazanavir Sulfate
3
2016
41
0.170
 Why?
Cytomegalovirus
1
2021
160
0.170
 Why?
Area Under Curve
2
2013
316
0.170
 Why?
No-Show Patients
1
2019
1
0.160
 Why?
Menstruation Disturbances
1
2019
12
0.160
 Why?
Diabetes Mellitus
2
2024
1035
0.160
 Why?
Brain Chemistry
1
2000
120
0.160
 Why?
Cytochrome P450 Family 3
1
2019
3
0.160
 Why?
Colorado
3
2024
4521
0.160
 Why?
Blood Pressure Monitoring, Ambulatory
1
2020
85
0.160
 Why?
Hemodynamics
1
2004
1114
0.160
 Why?
Cardiovascular Diseases
3
2024
2113
0.150
 Why?
Oligopeptides
2
2012
273
0.150
 Why?
Body Weight
2
2016
973
0.150
 Why?
Smoking
1
2006
1639
0.150
 Why?
Patients
1
2020
175
0.150
 Why?
Anti-Inflammatory Agents, Non-Steroidal
2
2013
350
0.150
 Why?
Lipids
2
2016
664
0.150
 Why?
Morphine
1
2000
160
0.150
 Why?
Child Health Services
1
2020
185
0.150
 Why?
Sitagliptin Phosphate
2
2021
33
0.150
 Why?
Double-Blind Method
2
2016
1987
0.150
 Why?
Progesterone
1
2019
251
0.140
 Why?
Ventricular Dysfunction
1
2018
16
0.140
 Why?
Treatment Outcome
7
2024
10821
0.140
 Why?
Body Mass Index
3
2019
2369
0.140
 Why?
Bariatric Surgery
1
2021
216
0.140
 Why?
Psychiatry
1
2020
181
0.140
 Why?
Apyrase
1
2017
17
0.140
 Why?
Organophosphonates
2
2008
92
0.130
 Why?
Healthy Volunteers
2
2019
204
0.130
 Why?
Pyridines
2
2012
508
0.130
 Why?
DNA Primers
3
2006
514
0.130
 Why?
Pyrophosphatases
1
2016
28
0.130
 Why?
Anti-HIV Agents
2
2016
775
0.130
 Why?
Chronic Disease
2
2017
1790
0.130
 Why?
Cardiology
1
2018
279
0.120
 Why?
Circadian Rhythm
1
2020
463
0.120
 Why?
GPI-Linked Proteins
1
2016
71
0.120
 Why?
Depression
2
2022
1408
0.120
 Why?
Gene Expression Regulation, Enzymologic
1
2017
285
0.120
 Why?
Ribavirin
1
2016
91
0.120
 Why?
Patient Care
1
2016
111
0.120
 Why?
Adenine
2
2008
268
0.120
 Why?
Students, Pharmacy
1
2016
97
0.120
 Why?
Metabolic Clearance Rate
2
2013
117
0.120
 Why?
Therapeutics
1
2015
14
0.120
 Why?
HIV Infections
4
2016
2830
0.120
 Why?
Education, Pharmacy
1
2016
120
0.120
 Why?
Voriconazole
1
2015
20
0.120
 Why?
beta-Cyclodextrins
1
2015
30
0.120
 Why?
Delivery of Health Care
1
2022
948
0.110
 Why?
Renal Replacement Therapy
1
2015
92
0.110
 Why?
Diltiazem
1
2014
29
0.110
 Why?
Patient Education as Topic
1
2019
766
0.110
 Why?
Surgical Procedures, Operative
1
2017
256
0.110
 Why?
Antifungal Agents
1
2015
137
0.110
 Why?
Chromosomes, Human, Pair 10
1
2013
19
0.110
 Why?
Antigens, CD
1
2017
524
0.110
 Why?
Phenotype
3
2024
3205
0.110
 Why?
Reoperation
1
2016
569
0.110
 Why?
Adolescent
6
2021
21555
0.100
 Why?
Cardiomyopathies
1
2017
350
0.100
 Why?
Medication Adherence
1
2017
471
0.100
 Why?
Kidney Transplantation
1
2019
701
0.100
 Why?
Half-Life
1
2013
166
0.100
 Why?
Venous Thromboembolism
1
2017
313
0.100
 Why?
Sirolimus
1
2014
275
0.100
 Why?
Tissue Distribution
2
2014
330
0.100
 Why?
Darunavir
1
2011
18
0.090
 Why?
Liver Transplantation
1
2019
872
0.090
 Why?
Practice Patterns, Physicians'
1
2020
1312
0.090
 Why?
Surveys and Questionnaires
2
2024
5772
0.090
 Why?
Self Care
1
2014
374
0.090
 Why?
Genetic Association Studies
1
2013
377
0.090
 Why?
Lung Transplantation
1
2014
309
0.090
 Why?
Acquired Immunodeficiency Syndrome
1
2012
233
0.090
 Why?
Reverse Transcriptase Inhibitors
2
2008
84
0.080
 Why?
Insulin Resistance
2
2010
1198
0.080
 Why?
Genetic Testing
2
2025
453
0.080
 Why?
Prevalence
1
2017
2719
0.080
 Why?
Patient Discharge
1
2016
895
0.080
 Why?
Cholesterol
1
2011
413
0.080
 Why?
Triglycerides
1
2011
525
0.080
 Why?
ATP-Binding Cassette Transporters
1
2010
138
0.080
 Why?
Leukocytes
2
2012
311
0.080
 Why?
Kidney Failure, Chronic
1
2015
565
0.080
 Why?
Lipoproteins
1
2010
168
0.080
 Why?
Longitudinal Studies
1
2016
2857
0.080
 Why?
Risk Assessment
3
2020
3439
0.070
 Why?
Lung Diseases
1
2014
768
0.070
 Why?
Databases, Factual
3
2021
1351
0.070
 Why?
Weight Gain
2
2021
518
0.070
 Why?
Incidence
2
2020
2792
0.070
 Why?
Indinavir
1
2006
7
0.070
 Why?
Drug Delivery Systems
1
2010
363
0.060
 Why?
Linear Models
2
2019
851
0.060
 Why?
Pyrimidinones
1
2007
114
0.060
 Why?
Genetic Techniques
1
2006
64
0.060
 Why?
Zidovudine
1
2006
78
0.060
 Why?
Factor X
1
2006
27
0.060
 Why?
Lamivudine
1
2006
64
0.060
 Why?
Prothrombin
1
2006
26
0.060
 Why?
Factor VII
1
2006
24
0.060
 Why?
Drug Utilization
1
2007
170
0.060
 Why?
Reproducibility of Results
1
2014
3292
0.060
 Why?
Chemokines, CXC
1
2006
70
0.060
 Why?
Oxidation-Reduction
1
2009
1059
0.060
 Why?
Base Sequence
2
2006
2180
0.060
 Why?
C-Reactive Protein
1
2008
411
0.060
 Why?
Regression Analysis
1
2008
1029
0.060
 Why?
Biomarkers
3
2014
4172
0.060
 Why?
Prognosis
2
2014
4031
0.060
 Why?
Delayed-Action Preparations
1
2006
180
0.060
 Why?
Pharmacovigilance
1
2024
23
0.060
 Why?
Health Care Surveys
1
2007
567
0.060
 Why?
Mathematical Computing
1
2004
11
0.060
 Why?
Gene Expression Regulation
1
2014
2615
0.060
 Why?
Gene Expression
1
2009
1505
0.060
 Why?
Drug Labeling
1
2004
40
0.050
 Why?
Risk Factors
3
2020
10356
0.050
 Why?
Infusions, Intravenous
1
2004
411
0.050
 Why?
Multidrug Resistance-Associated Proteins
3
2008
38
0.050
 Why?
Laboratories
1
2004
113
0.050
 Why?
Algorithms
3
2024
1702
0.050
 Why?
Kidney
2
2008
1472
0.050
 Why?
Reference Values
1
2004
821
0.050
 Why?
Drug Monitoring
1
2024
221
0.050
 Why?
Blood Coagulation
1
2024
254
0.050
 Why?
Socioeconomic Factors
1
2007
1286
0.050
 Why?
Linagliptin
1
2021
5
0.050
 Why?
Adamantane
1
2021
18
0.050
 Why?
Administrative Claims, Healthcare
1
2021
26
0.050
 Why?
Dipeptides
1
2021
50
0.050
 Why?
Electronic Prescribing
1
2021
3
0.040
 Why?
Uterine Hemorrhage
1
2021
33
0.040
 Why?
Electrocardiography
1
2004
632
0.040
 Why?
Protective Factors
1
2020
94
0.040
 Why?
Costs and Cost Analysis
1
2020
207
0.040
 Why?
Drug Tolerance
1
2000
105
0.040
 Why?
Treatment Failure
1
2020
353
0.040
 Why?
Homozygote
2
2012
203
0.040
 Why?
Kaplan-Meier Estimate
1
2021
892
0.040
 Why?
Animals
3
2008
37011
0.040
 Why?
Sex Factors
1
2024
2074
0.040
 Why?
Genomics
1
2024
793
0.040
 Why?
Glipizide
1
2018
6
0.040
 Why?
Attitude
1
2020
262
0.040
 Why?
Organic Anion Transport Protein 1
2
2008
6
0.040
 Why?
Proportional Hazards Models
1
2021
1263
0.040
 Why?
Glyburide
1
2018
32
0.040
 Why?
Antineoplastic Agents
1
2009
2145
0.040
 Why?
Liver
1
2006
1940
0.030
 Why?
Dexamethasone
1
2000
377
0.030
 Why?
Social Class
1
2019
277
0.030
 Why?
Feasibility Studies
1
2021
950
0.030
 Why?
Self-Management
1
2019
172
0.030
 Why?
Self Report
1
2021
831
0.030
 Why?
Membrane Transport Proteins
2
2008
163
0.030
 Why?
Anesthetics
1
2017
81
0.030
 Why?
Peru
1
2016
59
0.030
 Why?
Pharmaceutical Services
1
2016
84
0.030
 Why?
Tenofovir
2
2008
240
0.030
 Why?
Diabetic Angiopathies
1
2018
258
0.030
 Why?
Medicaid
1
2020
436
0.030
 Why?
Cause of Death
1
2018
431
0.030
 Why?
South Africa
1
2016
219
0.030
 Why?
Perioperative Care
1
2017
182
0.030
 Why?
Indians, North American
1
2021
625
0.030
 Why?
Alternative Splicing
1
2017
227
0.030
 Why?
Preoperative Care
1
2017
356
0.030
 Why?
Hepatitis C, Chronic
1
2016
164
0.030
 Why?
HEK293 Cells
1
2017
734
0.030
 Why?
Receptors, Steroid
1
2014
50
0.030
 Why?
Rats, Sprague-Dawley
1
2000
2501
0.030
 Why?
Everolimus
1
2014
91
0.030
 Why?
Demography
1
2014
292
0.030
 Why?
Hypoglycemia
1
2018
443
0.030
 Why?
Vasodilator Agents
1
2014
333
0.020
 Why?
Age Factors
1
2019
3301
0.020
 Why?
Heterozygote
1
2012
292
0.020
 Why?
Mental Disorders
1
2020
1083
0.020
 Why?
Rats
1
2000
5676
0.020
 Why?
Genetic Loci
1
2012
288
0.020
 Why?
Neoplasms
1
2024
2666
0.020
 Why?
Critical Illness
1
2015
809
0.020
 Why?
Insulin
1
2019
2398
0.020
 Why?
Multivariate Analysis
1
2012
1524
0.020
 Why?
Body Composition
1
2012
668
0.020
 Why?
Genetic Predisposition to Disease
1
2017
2420
0.020
 Why?
Plasma
1
2009
213
0.020
 Why?
Lopinavir
1
2007
30
0.020
 Why?
PubMed
1
2006
11
0.020
 Why?
Ribosomal Proteins
1
2006
82
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2007
272
0.020
 Why?
Pharmacology
1
2005
9
0.010
 Why?
Molecular Sequence Data
1
2009
2901
0.010
 Why?
Likelihood Functions
1
2005
143
0.010
 Why?
RNA, Messenger
1
2012
2838
0.010
 Why?
Cardiotonic Agents
1
2005
126
0.010
 Why?
Mitochondrial Proteins
1
2006
257
0.010
 Why?
Genome
1
2006
292
0.010
 Why?
Chromosome Mapping
1
2005
523
0.010
 Why?
Drug Therapy, Combination
1
2006
1060
0.010
 Why?
Hemorrhage
1
2008
723
0.010
 Why?
Predictive Value of Tests
1
2008
2039
0.010
 Why?
Saccharomyces cerevisiae Proteins
1
2006
404
0.010
 Why?
Models, Genetic
1
2005
607
0.010
 Why?
Pilot Projects
1
2006
1703
0.010
 Why?
Child
1
2020
22037
0.010
 Why?
Computer Simulation
1
2005
986
0.010
 Why?
Case-Control Studies
1
2007
3546
0.010
 Why?
Inflammation
1
2006
2837
0.010
 Why?
Aquilante's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (357) concept(s)
_
Co-Authors Expand Description
See all (53) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)